At GNRI our specialist teams collaborate with key partner organisations to deliver advanced research and development in biotechnology and diagnostics for the benefit of patients all over the world.
Our principal objective is to bring about a step change in the field of medical diagnostics: introducing new, effective and affordable solutions that offer significantly enhanced speed and accuracy.
From concept development to point-of-care, GNRI exists to enable real-time informed clinical decision-making in high risk scenarios where time and accuracy are critical factors.
In 2016 Great North Research & Innovation was founded by a clinician as a research and development company specialising in biotechnology and advanced diagnostics.
GNRI's principal mission is to alleviate the suffering caused by Sepsis; and as a company we remain dedicated to that purpose and to developing effective solutions that improve outcomes for patients.
The GNRI system provides information that enables clinicians to act rapidly, with the clarity of purpose that comes from peerless sensitivity and specificity: eliminating the harmful delays to effective therapeutic intervention in cases of Sepsis, and in other life-threatening infectious conditions.